Site and Treatment as fixed. [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2016-06-10 09:17 (3166 d 17:39 ago) – Posting: # 16426
Views: 6,578

Hi Dr Ripal,

❝ To be precise it is single dose two way cross over study of one of the taxanes and I am looking for the literature which supports evaluation of site effect and/or disease effect in bioequivalence studies.


Well, then it is a crossover and you need at least Site, Treatment, Sequence, Period, Subject in the model. Ideally Site has a high p-value.

❝ I have not come across literature of any patient based bioequivalence study which evaluates site effect as variable in statistical analysis.


Try harder. Google is your friend.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
249 visitors (0 registered, 249 guests [including 23 identified bots]).
Forum time: 01:56 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5